Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide as part of THE BALANCE GROUP and includes its residence in Mallorca, Spain. COGNIFUL is not a verified US treatment location. The American examples are selected services described by their providers, not an independent ranking or a comprehensive national directory. Their care levels and admission processes differ.

Dual diagnosis commonly refers to a substance-use disorder occurring with another mental health disorder. It can involve different combinations and does not establish a single cause. NIMH emphasizes comprehensive assessment because mental health and substance-use symptoms can overlap. [1]

Tell the clinician about current symptoms, the pattern of use, medication, physical health and earlier care. Describe periods when either concern changed and what treatment was taking place. The timeline can be useful even when some dates are uncertain.

Ask what the assessment needs to clarify immediately and what may require review over time. A useful plan can identify current priorities while acknowledging that some diagnostic questions remain open.

Do not assume that the person must choose between an addiction explanation and a mental health explanation. NIMH describes influences in both directions and shared contributing factors. The aim is appropriate coordinated care, not forcing the history into a single story. [1]

A provider’s network may contain several different pathways. Confirm the actual site, program and professionals rather than assuming that every listed service is delivered within one residence. The next step should follow a clinical recommendation and current admission review.

NIMH describes integrated care as combining mental health and substance-use treatment, potentially using behavioral therapies, medication and care management. The person should understand how these components relate to the assessment and to each other. [1]

Ask who leads the overall plan and how professionals communicate. If addiction treatment, psychotherapy and prescribing involve different clinicians, clarify who reviews changes and how conflicting advice is resolved. Separate appointments alone do not explain coordination.

Fernside describes psychiatric evaluation, medication management, individual and group work and aftercare planning within its residential model. Ask how the actual proposal addresses the person’s mental health condition and substance-use needs rather than relying on the broad dual-diagnosis label. [2]

The plan should also explain what the provider cannot supply. A residence may be appropriate for some combinations of needs while another person requires a hospital or different specialist service. An honest scope discussion is part of informed selection.

Tell the assessing professional about possible withdrawal, previous medical complications and the complete pattern of use. Do not abruptly stop alcohol or prescribed medication to prepare for a residence. The appropriate setting and sequence require clinical assessment.

ASAM describes alcohol withdrawal management as a component of treatment engagement, not sufficient treatment for alcohol use disorder by itself. A dual-diagnosis plan should identify what ongoing addiction and mental health care follows that phase. [6]

For opioid use disorder, CDC advises offering or arranging evidence-based medication treatment and advises against detoxification alone without medication. Ask how that treatment will continue across any move between services. A preference for residential care should not interrupt an appropriate medication pathway. [7]

Mount Sinai’s hospital service describes assessment, detoxification when indicated and rehabilitation with medical and psychiatric care. The exact route should be selected according to the person’s needs. Its capabilities should not be assumed for a separate non-hospital residence. [3]

If depression, anxiety or trauma-related symptoms are present, ask what assessment and treatment are proposed for them. A substance-use program should not leave those needs undefined or assume that all symptoms will resolve when use changes.

Likewise, a mental health improvement should not be treated as proof that addiction care is complete. NIMH’s integrated-care guidance supports considering both areas together. Ask how the team will assess functioning and review priorities over time. [1]

A person may already have a useful relationship with a therapist or psychiatrist. Discuss whether that clinician can contribute information or receive an authorized handover. A residential phase should not create unnecessary uncertainty about the next clinical relationship.

COGNIFUL’s co-occurring-needs review considers symptoms, substance use, medication, health, previous treatment and daily functioning together. Clinical suitability determines whether its shared residence can meet the combination of needs. The proposed plan should identify its purpose and any external clinical arrangements required. [5]

The residence supports a maximum of four clients at any time, each with a private suite. Clinical sessions and bodywork are individual. The residence, chef, personal manager, other holistic sessions, excursions and activities are shared. Ask how that format fits the person’s current support needs and preferences. [8]

A limited client capacity does not establish staffing ratios, a named therapy or hospital capability. Acute medical, psychiatric and withdrawal needs may require another setting before the residential phase. Confirm the professionals and services in the personal proposal rather than inferring them from accommodation or shared team biographies. [9]

COGNIFUL Premier and Premier Plus both provide assessment, a personal treatment plan and continuing-care planning. COGNIFUL Premier Plus adds further individual therapeutic work, family and transition work, and three months of aftercare. Follow-up in the base program is agreed individually. A typical stay lasts four to twelve weeks and is reviewed clinically. [10] View program fees

Ask what added therapeutic or transition work is relevant to the actual US return plan. It may need to connect with ongoing addiction treatment, psychiatric care, family support or professional responsibilities. The higher fee is not a reason by itself to select the Plus program.

COGNIFUL’s continuing-care process addresses routines, relationships, local support and authorized coordination. Confirm the receiving clinicians and first appointments before relying on a general aftercare offer. The scope of follow-up and the person’s actual state or country may affect which services can be delivered; unrestricted remote prescribing or treatment should not be assumed. [11]

COGNIFUL generally operates on a self-pay basis and does not bill insurers directly or guarantee reimbursement. The written proposal should explain the total services, inclusions, costs and separate arrangements. Compare the complete pathway with appropriate US options before committing to international travel.

Prescribed treatment, physical dependence, withdrawal and a substance-use disorder are different assessment questions. COGNIFUL’s co-occurring guidance makes those distinctions. Entering a residential program should not automatically be interpreted as needing to stop every prescription. [5]

Provide the prescribed instructions and an accurate account of actual use, including recent interruptions and non-prescription products. Ask who reviews benefits, unwanted effects and interactions and how monitoring continues after a change of setting.

When several prescribers are involved, ask the clinicians to coordinate rather than leaving the person to reconcile inconsistent advice. The plan should identify who is responsible at each stage and how changes are communicated.

A national or international program may be far from the person’s home clinicians. Tell the team where you will actually live after treatment, including any planned move or frequent travel. The next appointments must be feasible in that location.

Caron’s Florida description illustrates why exact sites matter: the Keele Center in Delray Beach and Renaissance in Boca Raton have distinct roles. Similar questions should be asked of any multi-site provider. Regional branding cannot tell you where a particular phase will occur. [4]

Arrange the receiving addiction and mental health professionals before discharge when possible. A summary should identify the assessment, work completed, medication responsibilities and unresolved questions. The person should understand the next steps as well as the receiving team.

NIMH identifies behavioral approaches such as CBT, motivational interviewing and contingency management as possible components of co-occurring care. Ask which approach is proposed, what it addresses and how progress is reviewed. A method should relate to the person’s needs and concerns about change, not simply appear as another item in a program description. [1]

Clarify who may receive clinical updates if relatives or advisers help organize treatment. Payment, transport and family therapy are different roles. The person receiving care should understand and consent to the information-sharing arrangement.

If family work is proposed, ask what it will address and how participation is chosen. A program should not assume that every relationship can be involved in the same way. Practical support should serve the assessed plan rather than create additional pressure.

Ask how the team considers substance use, mental health symptoms, participation and everyday functioning together. Improvement may occur unevenly, and the plan should explain how that information informs the next decision.

If symptoms worsen or use recurs, ask how safety, support and treatment will be reviewed. The response should be clinically useful and clear about appropriate local services. A person should not feel required to hide difficulties to preserve the appearance of progress.

Is dual diagnosis one specific disorder?

No. It describes co-occurring substance-use and mental health disorders, which can involve different combinations. Assessment should identify the actual needs and priorities.

Can detoxification resolve both concerns?

Withdrawal management addresses a particular phase. Ongoing addiction and mental health treatment may still be required. Ask the clinical team to explain the complete pathway.

Does COGNIFUL provide an American residential service?

No verified US COGNIFUL residence is described here. Its program is in Mallorca, Spain, and needs a suitable international and return-home plan.

What makes a proposal easier to compare?

A clear explanation of care level, professional responsibilities, treatment goals, medical needs and continuing care. Obtain the written services and costs so that the whole plan can be evaluated.

1. Finding Help for Co-Occurring Substance Use and Mental Disorders — National Institute of Mental Health.
2. Residential Addiction Treatment at Fernside at McLean — Mass General Brigham.
3. Inpatient Addiction Treatments — Mount Sinai.
4. Addiction Treatment in Delray Beach, Florida — Caron Treatment Centers.
5. Private Dual Diagnosis Treatment and Co-Occurring Needs — COGNIFUL.
6. Clinical Practice Guideline on Alcohol Withdrawal Management — American Society of Addiction Medicine.
7. Opioid Use Disorder: Treating — Centers for Disease Control and Prevention.
8. How Residential Treatment Works — COGNIFUL.
9. Clinical Scope, Suitability and Care Coordination — COGNIFUL.
10. Programs, Fees and Admissions — COGNIFUL.
11. Continuing Care and Reintegration — COGNIFUL.